ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

ARCT Arcturus Therapeutics Holdings Inc

38.81
0.33 (0.86%)
May 31 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 480,632
Bid Price 36.38
Ask Price 39.61
News -
Day High 39.82

Low
17.52

52 Week Range

High
43.81

Day Low 38.05
Share Name Share Symbol Market Stock Type
Arcturus Therapeutics Holdings Inc ARCT NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.33 0.86% 38.81 19:00:00
Open Price Low Price High Price Close Price Previous Close
38.52 38.05 39.82 38.81 38.48
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
9,058 480,632 US$ 39.02 US$ 18,754,733 - 17.52 - 43.81
Last Trade Type Quantity Price Currency
18:25:06 6 US$ 39.56 USD

Arcturus Therapeutics Holdings Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.04B 26.92M - 166.8M -29.73M -1.10 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Arcturus Therapeutics News

Date Time Source News Article
5/28/202405:30Business WireArcturus Therapeutics Announces Positive Development for..
5/22/202406:00GlobeNewswire Inc.Achilles Therapeutics Announces Research Collaboration with..
5/20/202407:30Business WireNature Communications Publishes Pivotal Data Demonstrating..
5/15/202415:01Business WireArcturus Therapeutics to Attend Upcoming Investor &..
5/08/202415:17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/08/202415:05Edgar (US Regulatory)Form 8-K - Current report
5/08/202415:01Business WireArcturus Therapeutics Announces First Quarter 2024 Financial..
4/25/202415:01Business WireArcturus Therapeutics to Report First Quarter Financial..
3/07/202415:05Edgar (US Regulatory)Form 8-K - Current report
3/07/202415:01Business WireArcturus Therapeutics Announces Fourth Quarter and Fiscal..
2/26/202408:00Business WireArcturus Therapeutics to Present at the Barclays 26th Annual..
2/23/202415:05Edgar (US Regulatory)Form 8-K - Current report
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ARCT Message Board. Create One! See More Posts on ARCT Message Board See More Message Board Posts

Historical ARCT Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week31.0339.8230.2737.32596,1587.7825.07%
1 Month27.6439.8226.2831.23480,11411.1740.41%
3 Months35.9939.8225.4131.48516,9522.827.84%
6 Months24.5443.8122.3532.33458,86114.2758.15%
1 Year26.5743.8117.5229.89438,45912.2446.07%
3 Years29.6064.973511.7029.09535,8029.2131.11%
5 Years6.69129.715.7539.39570,18832.12480.12%

Arcturus Therapeutics Description

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the segment of research and development of medical applications for nucleic acid-focused technology. The product pipeline of the company includes LUNAR-OTC, LUNAR-CF, and LUNAR-COV19.